BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1137503)

  • 1. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and immune response to rubella subunits vaccines.
    Cappel R; De Cuyper F
    Arch Virol; 1976; 50(3):207-13. PubMed ID: 1259596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the response of lymphocytes to phytohemagglutinin in rubella.
    McMorrow LE; Vesikari T; Wolman SR; Giles JP; Cooper LZ
    J Infect Dis; 1974 Nov; 130(5):464-9. PubMed ID: 4423757
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent rubella infection and rubella-associated arthritis.
    Chantler JK; Ford DK; Tingle AJ
    Lancet; 1982 Jun; 1(8285):1323-5. PubMed ID: 6123637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
    Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
    Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
    Vesikari T; Buimovici-Klein E
    Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
    Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
    J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cellular immunity to rubella virus in congenital rubella.
    Fuccillo DA; Steele RW; Hensen SA; Vincent MM; Hardy JB; Bellanti JA
    Infect Immun; 1974 Jan; 9(1):81-4. PubMed ID: 4808855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.
    Smith KA; Chess L; Mardiney MR
    Cell Immunol; 1973 Aug; 8(2):321-7. PubMed ID: 4725863
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of live attenuated rubella virus vaccines.
    Andzhaparidze OG; Desyatskova RG; Chervonski GI; Pryanichnikova LV
    Am J Epidemiol; 1970 May; 91(5):527-30. PubMed ID: 5462118
    [No Abstract]   [Full Text] [Related]  

  • 16. Rubella vaccines and the immunity gap.
    Andre FE; Florent G; du Pan RM
    Lancet; 1979 Aug; 2(8139):417-8. PubMed ID: 89471
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.
    Plotkin SA; Farquhar JD; Ogra PL
    JAMA; 1973 Aug; 225(6):585-90. PubMed ID: 4740523
    [No Abstract]   [Full Text] [Related]  

  • 19. Rubella precipitin response in natural infection and in vaccination.
    Paul NR; Rhodes AJ; Campbell JB; Labzoffsky NA
    Arch Gesamte Virusforsch; 1974; 45(4):335-51. PubMed ID: 4216341
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection.
    Morag A; Morag B; Bernstein JM; Beutner K; Ogra PL
    J Infect Dis; 1975 Apr; 131(4):409-16. PubMed ID: 1117197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.